Els Hubloux
Chief Investment Officer at QUEST FOR GROWTH NV
Network origin in Els Hubloux first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Private Eq Fd/Alt Invt | Investment Managers | 13 | |
Capricorn Partners NV
 Capricorn Partners NV Investment ManagersFinance Capricorn Partners NV (Capricorn) is an independent European licensed manager of private and public equity investment funds which was founded in 1993 as a joint venture between Dr Jos B. Peeters and Baring Venture Partners Ltd. In 1999, Capricorn became a fully partner-owned, independent firm. It is headquartered in Leuven, Belgium.
10
| Private Company | Investment Managers | 10 |
QBIC Venture Partners BV
 QBIC Venture Partners BV Investment ManagersFinance QBIC Venture Partners BVBA (QBIC Venture Partners) is a venture capital firm founded in 2012 by Marc Zabeau. The firm is headquartered in Belgium.
5
| Private Company | Investment Managers | 5 |
DeuterOncology SA
 DeuterOncology SA BiotechnologyHealth Technology DeuterOncology SA is a Belgian preclinical-stage biotechnology company that specializes in developing targeted cancer therapies. DeuterOncology is based in Liege, BE. The company's focus is on creating a first-in-class dual MET and RAS pathway inhibitor. The company was founded in 2020 by Timothy Perera, who has been the CEO since 2020.
5
| Holding Company | Biotechnology | 5 |
Newton Biocapital Partners SRL
 Newton Biocapital Partners SRL Investment ManagersFinance Newton Biocapital Partners SPRL is an Independent Venture Capital firm founded in 2017 by Alain Parthoens. Newton Biocapital Partners SPRL is headquartered in Woluwe-Saint-Pierre.
4
| Private Company | Investment Managers | 4 |
Quest Management SA (Private Equity)
 Quest Management SA (Private Equity) Investment ManagersFinance Quest Management NV/SA is an independent partner-owned investment management firm specialized in emerging technologies and life sciences. Quest was established in 1998 with the venture capital firm Capricorn Venture Partner as a co-founder, and is located in Leuven in the Flemish region of Belgium. Quest manages Luxembourg-domiciled funds, including a US dollar-denominated SICAV and the Belgian collective private equity investment vehicle Quest for Growth (XB: QFG), which was the first investment company set up as a tax-advantaged Privak.
1
| Extinct | Investment Managers | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Els Hubloux via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| MDXHEALTH SA | Medical Specialties | Director/Board Member Director/Board Member | |
Galapagos Biotech Ltd.
 Galapagos Biotech Ltd. BiotechnologyHealth Technology Galapagos Biotech Ltd. operates as a drug discovery company which provides discovery technologies and services. Its technologies include Chemogenomics and Silico. The company was founded by Kenneth Leslie Powell and Janet Maureen Thornton in July 8, 1997 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Chairman Director/Board Member | |
Tibotec Virco NV
 Tibotec Virco NV Miscellaneous Commercial ServicesCommercial Services Tibotec-Virco NV develops drugs and individualized disease management products. The firm also offers early stage research programs concentrating on the development of treatments for cancer, hepatitis C, and other infectious diseases. The company also provides HIV drug resistance testing and other analytical services in the United States, Japan, Europe, Canada, and Australia. It has operations in Belgium, North Carolina, Ireland, and the United Kingdom. It was founded in by Paul Stoffels in March, 2001 and is headquartered in Mechelen, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
| INSEAD | College/University | Masters Business Admin Corporate Officer/Principal Masters Business Admin | |
| INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ABLYNX | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member | |
Gimv Information & Communication Technology ICT
 Gimv Information & Communication Technology ICT Investment ManagersFinance Gimv Information & Communication Technology ICT (Gimv-ICT) is the venture capital division of Belgium's Gimv NV (XB: GIMB), an investment firm founded in 1980. Based in Antwerp, the firm focuses on investing in high growth companies in the telecommunications, software and electronics industries. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
| NEXSTIM PLC | Medical Specialties | Director/Board Member Director/Board Member | |
| Ghent University | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
| Katholieke Universiteit Leuven | College/University | Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree Graduate Degree | |
| Université Libre de Bruxelles | College/University | Graduate Degree Doctorate Degree | |
Ogeda SA
 Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | Pharmaceuticals: Major | Director/Board Member | |
| Vlerick Leuven Gent Management School | College/University | Graduate Degree Director of Finance/CFO | |
PharmaDM NV
 PharmaDM NV Packaged SoftwareTechnology Services PharmaDM NV provides drug discovery data analysis solutions. It offers its solutions based on mining integrated chemical, biological, and clinical data. The firm's products include DMax, AlphaDMax, and IDMax. The company was founded by Dr. Luc Dehaspe, Dr. Ross D. King, and Dr. Ashwin Srinivasan in November 2000 and is headquartered in Heverlee, Belgium. | Packaged Software | Founder | |
IMEC VZW /Private Equity/
 IMEC VZW /Private Equity/ Investment ManagersFinance IMEC VZW (Private Equity) (IMEC) is a operating division of Interuniversitair Micro-Electronica Centrum VZW founded in 1984. The firm is headquartered in Leuven, Belgium. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Université Catholique de Louvain | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
Vesalius Biocapital Partners SARL
 Vesalius Biocapital Partners SARL Investment ManagersFinance Vesalius Biocapital Partners SARL (Vesalius Biocapital Partners) is an independent venture capital firm founded in 2007 by Stéphane Verdood. The firm is headquartered in Luxembourg. | Investment Managers | Private Equity Investor | |
Trinean NV
 Trinean NV Electronic Equipment/InstrumentsElectronic Technology Trinean NV develops and produces nanoliter spectrophotometers and consumables. Its products include DropSense96, Xpose, and spectral content profiling. The firm covers both microfluidic structures and multi-channel spectrometry for microliter sample handling. The company was founded by Ronny Baeckstaele and Kris Naessens in 2006 and is headquartered in Gentbrugge, Belgium. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member Director/Board Member | |
| VOLUNTIS S.A. | Packaged Software | Director/Board Member | |
ProFibrix BV
 ProFibrix BV BiotechnologyHealth Technology ProFibrix BV develops and markets products for the hemostasis and regenerative medicine markets. Its product in pipeline, ProFibrix, is a hemostatic agent for mild to moderate surgical bleeding. The firm operates through its offices located in Leiden and Seattle. It is a subsidiary of The Medicines Company. The company was founded in 2004 by Jaap Koopman and is headquartered in Leiden, the Netherlands. | Biotechnology | Director/Board Member | |
FlandersBio vzw
 FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen. | Miscellaneous Commercial Services | Chairman Corporate Officer/Principal | |
PROMETHERA Biosciences SA
 PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Pharmaceuticals: Major | Director/Board Member | |
ST Engineering iDirect (Europe) NV
 ST Engineering iDirect (Europe) NV Computer CommunicationsElectronic Technology ST Engineering iDirect (Europe) CY NV manufactures and markets satellite communication equipment. It offers professional equipment, broadband systems, and IP software solutions. The firm provides modems, satellite terminals, modulators and receivers. The company was founded by Dirk Breynaert and Jean-Marie Maes in 1985 and is headquartered in Sint-Niklaas, Belgium. | Computer Communications | Director/Board Member | |
| Alcatel-Lucent Bell NV | Chief Tech/Sci/R&D Officer | ||
Leuven.Inc Vzw
 Leuven.Inc Vzw Miscellaneous Commercial ServicesCommercial Services Leuven.Inc Vzw provides administration and management consulting services. The company was founded by Imec, Arthur Andersen and Fortis Bank in 1999 and is headquartered in Leuven, Belgium. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| University of Antwerp | College/University | Graduate Degree Masters Business Admin | |
| Vesalius Biocapital II Partners SARL | Founder | ||
Capricorn Venture Partners NV (Investment Management)
 Capricorn Venture Partners NV (Investment Management) Investment ManagersFinance Capricorn Venture Partners NV (Investment Management) (Capricorn Partners-IM) is the investment management division of Capricorn Venture Partners NV, a private venture company headquartered in Leuven, Belgium. The firm was founded in 1993 as a joint venture between Dr. Jos B. Peeters and Baring Venture Partners Ltd. They were renamed as Capricorn Venture Partners in 2019. Capricorn Partners-IM manages private and public equity investment funds for retail and institutional investors. | Investment Managers | Chief Executive Officer Head-Equity Investments | |
| Solvay Business School of Economics & Management | College/University | Undergraduate Degree | |
Volta Management NV
 Volta Management NV Investment ManagersFinance Founded in 2014 by founder Frank Maene, Volta Management NV is a venture capital firm headquartered in Ghent of Belgium. | Investment Managers | Private Equity Investor | |
Bio-Sourcing SA
 Bio-Sourcing SA BiotechnologyHealth Technology Bio-Sourcing SA develops and markets biological drugs for veterinary use. The firm focuses on farm animal health and companion animal health. The company was founded by Bertrand Mérot in June 2011 and is headquartered in Liege, Belgium. | Biotechnology | Director/Board Member | |
Track4C NV
 Track4C NV Packaged SoftwareTechnology Services Track4C NV develops software related to container tracking and tracing solutions. It provides geographical location of containers, unauthorized opening of container doors, and environmental condition inside containers. The company was founded by Jan Van Herbruggen and Gustaaf Van den Bulck in 2012 and is headquartered in Aartselaar, Belgium. | Packaged Software | Director/Board Member | |
Molecubes NV
 Molecubes NV Medical SpecialtiesHealth Technology Molecubes NV develops and sells benchtop preclinical imaging systems. Its products include Y-Cube, X-Cube, ß-cube, and Animal Monitoring. The company was founded by Vincent Keereman, Roel Van Holen, and Ewout Vansteenkiste on December 23, 2015 and is headquartered in Gent, Belgium. | Medical Specialties | Director/Board Member | |
Confo Therapeutics NV
 Confo Therapeutics NV Pharmaceuticals: MajorHealth Technology Confo Therapeutics NV develops pharmaceutical products. It is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need. The company was founded by Jan Steyaert and Toon Laeremans in June 2015 and is headquartered in Brussels, Belgium. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Venture Spirit
 Venture Spirit Packaged SoftwareTechnology Services Venture Spirit operates as business management consultant. It offers boost energy & get buy-in, grow global teamwork, change and learn, create and uncover ideas services. The company was founded in 2010 and is headquartered in Zele, Belgium. | Packaged Software | Director/Board Member | |
Sentiance NV
 Sentiance NV Data Processing ServicesTechnology Services Sentiance NV engages in the provision of internet of things solutions. It offers insurance, health, commerce, mobility, connected car, smart home, and smart city services. The company was founded by Filip Maertens in 2011 and is headquartered in Antwerp, Belgium. | Data Processing Services | Director/Board Member | |
| ACTICOR BIOTECH SAS | Biotechnology | Director/Board Member | |
| InnoConsult BV | Corporate Officer/Principal | ||
Morrow NV
 Morrow NV Miscellaneous Commercial ServicesCommercial Services Morrow NV develops researching technology for digital lenses. It provides eyecare services. The company was founded by Jelle de Smet and Paul Marchal and is headquartered in Zwijnaarde, Netherlands. | Miscellaneous Commercial Services | Director/Board Member | |
Ncardia SA
 Ncardia SA Miscellaneous Commercial ServicesCommercial Services Ncardia SA engages in drug discovery research and development. Its cardiac products encompass hiPSC-derived Pluricyte, Cardiomyocytes, Cor.4U cardiomyocytes and vCor.4U ventricular cardiomyocytes and FibroCor.4U cardiac fibroblasts. The company is headquartered in Gosselies, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
Arkite NV
 Arkite NV Packaged SoftwareTechnology Services Arkite NV develops and offers human interface mate which provides virtual assistance. The company was founded by Johan Smeyers and Ives De Saeger in 2015 and is headquartered in Hemiksem, Belgium. | Packaged Software | Director/Board Member | |
| AQ Partners SRL | Corporate Officer/Principal | ||
Epics Therapeutics SA
 Epics Therapeutics SA Miscellaneous Commercial ServicesCommercial Services EPICS Therapeutics SA engages in the development of therapeutic solutions for cancer. The company was founded by Jean Combalbert, Alain Parthoens and Francois Fuks on February 20, 2018 and is headquartered in Charleroi, Belgium. | Miscellaneous Commercial Services | Founder | |
Ncardia Holding SA
 Ncardia Holding SA BiotechnologyHealth Technology Ncardia Holding SA provides biotech research and development, business management consulting, technical testing, and administrative services. The private company is based in Mont-Saint-Guibert, Belgium. The Belgian company was founded in 2014. Stefan Braam has been the CEO of the company since 2015. | Biotechnology | Director/Board Member | |
Cellaïon SA
 Cellaïon SA BiotechnologyHealth Technology Cellaïon SA is a biotech company located in Mont Saint Guibert, Belgium. Cellaïon aims to restore a favorable environment to reboost the regenerative process of the liver and ensure a second life to the native liver instead of losing it. The Belgian company has a strong IP base issued from their own research and academic research at UCLouvain, developed with the objective to generate new products. Cellaïon's treatment covers the wide spectrum of liver diseases, from the highly life-threatening acute-on-chronic liver-failure (ACLF) and acute alcoholic hepatitis, to intermediate severity acute decompensation of cirrhosis (AD) and progressive chronic liver diseases caused by non-alcoholic steatohepatitis (NASH). The company has built up a series of R&D and collaborative partnerships with both industrial and academic partners, allowing Cellaïon to broaden and accelerate its clinical development. The company was founded by Etienne Marc Sokal, who has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
| A Q Invest SRL | Corporate Officer/Principal |
Statistics
International
| Belgium | 41 |
| France | 5 |
| Luxembourg | 3 |
| Netherlands | 3 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 17 |
| Consumer Services | 9 |
| Commercial Services | 8 |
| Finance | 7 |
| Technology Services | 7 |
Operational
| Director/Board Member | 141 |
| Chairman | 36 |
| Private Equity Investor | 32 |
| Corporate Officer/Principal | 29 |
| Independent Dir/Board Member | 17 |
Most connected contacts
| Insiders | |
|---|---|
| Edwin Moses | 35 |
| Alain Parthoens | 29 |
| Staf van Reet | 22 |
| Ekaterina Smirnyagina | 21 |
| Martin de Prycker | 21 |
| Frank Bulens | 20 |
| Paul van Dun | 15 |
| Katrin Geyskens | 10 |
| Regine Slagmulder | 9 |
| Els Vanheusden | 8 |
| Marc Lambrechts | 8 |
| Marc Zabeau | 7 |
| Brigitte de Vet-Veithen | 7 |
| Jozef Clijsters | 7 |
| Sofie Baeten | 7 |
- Stock Market
- Insiders
- Els Hubloux
- Company connections